Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations

Singapore Med J. 2019 Jan;60(1):34-39. doi: 10.11622/smedj.2018078. Epub 2018 Jun 21.

Abstract

Introduction: To study the prevalence of hepatitis C virus (HCV) infection in blood donor (BD), haemodialysis (HD) and intravenous drug user (IVDU) populations in Singapore and assess the IL28B polymorphism if HCV positive.

Methods: The BD population were healthy volunteers, the HD population were patients who were on haemodialysis for at least six months of follow-up between January 2009 and December 2014. IVDU population was from inmates at halfway houses who consented.

Results: Between 2011 and 2014, of 161,658 individuals who underwent screening prior to blood donation, 95 (0.059%) were positive for HCV. Of the 42 sera available, common genotypes (GTs) were GT-3 (47.6%) and GT-1 (31.0%). Of 1,575 HD patients, 2.2% were anti-HCV positive. The HCV GT distribution was HCV GT-1 (32.4%), HCV GT-3 (20.5%) and GT-6 (8.8%). 83 halfway house inmates were screened. Of the 47 IVDUs, 36.2% were anti-HCV positive with predominant GT-3 (%). IL28B polymorphism was noted to be CC predominantly 85.3%.

Conclusion: Prevalence of HCV infection has decreased in both the BD and HD populations. However, it remains high in the IVDU population. GT-1 remains the most common in the HD population; however, GT-3 infection is now more common among the BD population in Singapore. IL28B - CC is the predominant variant among the HCV-infected individuals in Singapore.

Keywords: HCV genotype; IL28B; Singapore; hepatitis C; prevalence.

MeSH terms

  • Acute Kidney Injury / blood
  • Acute Kidney Injury / complications*
  • Adult
  • Alleles
  • Blood Donors*
  • Female
  • Genotype
  • Hepatitis C / epidemiology*
  • Humans
  • Interferons
  • Interleukins / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Prevalence
  • Renal Dialysis
  • Singapore / epidemiology
  • Substance Abuse, Intravenous / blood
  • Substance Abuse, Intravenous / epidemiology*
  • Young Adult

Substances

  • interferon-lambda, human
  • Interleukins
  • Interferons